Canada Life’s Collegium Pharmaceutical COLL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $921K | Hold |
27,843
| – | – | ﹤0.01% | 1377 |
|
|
2025
Q4 | $1.29M | Sell |
27,843
-12,090
| -30% | -$506K | ﹤0.01% | 1312 |
|
|
2025
Q3 | $1.38M | Hold |
39,933
| – | – | ﹤0.01% | 1352 |
|
|
2025
Q2 | $1.18M | Sell |
39,933
-1,838
| -4% | -$52.4K | ﹤0.01% | 1379 |
|
|
2025
Q1 | $1.25M | Sell |
41,771
-3,694
| -8% | -$113K | ﹤0.01% | 1367 |
|
|
2024
Q4 | $1.3M | Hold |
45,465
| – | – | ﹤0.01% | 1403 |
|
|
2024
Q3 | $1.76M | Hold |
45,465
| – | – | ﹤0.01% | 1344 |
|
|
2024
Q2 | $1.46M | Buy |
45,465
+13,613
| +43% | +$472K | ﹤0.01% | 1403 |
|
|
2024
Q1 | $1.24M | Buy |
31,852
+4,742
| +17% | +$166K | ﹤0.01% | 1446 |
|
|
2023
Q4 | $835K | Sell |
27,110
-5,294
| -16% | -$133K | ﹤0.01% | 1558 |
|
|
2023
Q3 | $724K | Buy |
32,404
+1,510
| +5% | +$34.4K | ﹤0.01% | 1584 |
|
|
2023
Q2 | $664K | Sell |
30,894
-92
| -0.3% | -$2.09K | ﹤0.01% | 1615 |
|
|
2023
Q1 | $743K | Sell |
30,986
-12,239
| -28% | -$325K | ﹤0.01% | 1584 |
|
|
2022
Q4 | $1M | Sell |
43,225
-438
| -1% | -$8.83K | ﹤0.01% | 1520 |
|
|
2022
Q3 | $699K | Buy |
43,663
+10,278
| +31% | +$181K | ﹤0.01% | 1608 |
|
|
2022
Q2 | $592K | Buy |
33,385
+4,512
| +16% | +$75.9K | ﹤0.01% | 1636 |
|
|
2022
Q1 | $602K | Sell |
28,873
-1,059
| -4% | -$20K | ﹤0.01% | 1660 |
|
|
2021
Q4 | $559K | Hold |
29,932
| – | – | ﹤0.01% | 1684 |
|
|
2021
Q3 | $596K | Hold |
29,932
| – | – | ﹤0.01% | 1689 |
|
|
2021
Q2 | $708K | Hold |
29,932
| – | – | ﹤0.01% | 1647 |
|
|
2021
Q1 | $708K | Buy |
29,932
+27,658
| +1,216% | +$657K | ﹤0.01% | 1644 |
|
|
2020
Q4 | $45K | Hold |
2,274
| – | – | ﹤0.01% | 2317 |
|
|
2020
Q3 | $47K | Hold |
2,274
| – | – | ﹤0.01% | 2192 |
|
|
2020
Q2 | $40K | Hold |
2,274
| – | – | ﹤0.01% | 2291 |
|
|
2020
Q1 | $37K | Hold |
2,274
| – | – | ﹤0.01% | 2218 |
|
|
2019
Q4 | $46K | Buy |
+2,274
| New | +$37.9K | ﹤0.01% | 2288 |
|
|
2019
Q3 | – | Sell |
-4,286
| Closed | -$56K | – | 1369 |
|
|
2019
Q2 | $56K | Hold |
4,286
| – | – | ﹤0.01% | 2412 |
|
|
2019
Q1 | $65K | Buy |
4,286
+2,886
| +206% | +$46.2K | ﹤0.01% | 2195 |
|
|
2018
Q4 | $23K | Hold |
1,400
| – | – | ﹤0.01% | 2524 |
|
|
2018
Q3 | $21K | Hold |
1,400
| – | – | ﹤0.01% | 2501 |
|
|
2018
Q2 | $33K | Hold |
1,400
| – | – | ﹤0.01% | 2469 |
|
|
2018
Q1 | $36K | Hold |
1,400
| – | – | ﹤0.01% | 2429 |
|
|
2017
Q4 | $26K | Hold |
1,400
| – | – | ﹤0.01% | 2475 |
|
|
2017
Q3 | $15K | Hold |
1,400
| – | – | ﹤0.01% | 2508 |
|
|
2017
Q2 | $17K | Hold |
1,400
| – | – | ﹤0.01% | 2508 |
|
|
2017
Q1 | $14K | Hold |
1,400
| – | – | ﹤0.01% | 2484 |
|
|
2016
Q4 | $22K | Hold |
1,400
| – | – | ﹤0.01% | 2475 |
|
|
2016
Q3 | $27K | Hold |
1,400
| – | – | ﹤0.01% | 2442 |
|
|
2016
Q2 | $17K | Buy |
+1,400
| New | +$23.1K | ﹤0.01% | 2481 |
|
Other funds holding COLL
EAM
VCM
Canada Life's COLL Position: Q1 2026 in Review
Canada Life held its Collegium Pharmaceutical (COLL) position steady in Q1 2026 at 27,843 shares worth $921K. The position accounts for ﹤0.01% of the portfolio, ranked #1377.
Canada Life first reported a position in COLL in Q2 2016 and has held it in 39 quarters since. The position peaked at $1.76M in Q3 2024. 266 funds tracked by Wall St. Rank hold COLL as of Q1 2026.
- Canada Life held 27,843 shares of Collegium Pharmaceutical worth $921K as of Q1 2026.
- Canada Life left its Collegium Pharmaceutical share count unchanged in Q1 2026.
- Collegium Pharmaceutical made up ﹤0.01% of Canada Life's portfolio in Q1 2026, its #1377 holding.
- Canada Life first reported a position in Collegium Pharmaceutical in Q2 2016 and has held it in 39 quarters since.
- Canada Life's Collegium Pharmaceutical position peaked at $1.76M in Q3 2024.
- 266 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q1 2026.
Based on Canada Life's 13F filing for Q1 2026, filed 14 May 2026.